Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

The ESG Weekly: Carbon emissions and pandemics, then we discuss how drugs are rushed forward

The ESG Weekly: Carbon emissions and pandemics, then we discuss how drugs are rushed forward

FromESG now


The ESG Weekly: Carbon emissions and pandemics, then we discuss how drugs are rushed forward

FromESG now

ratings:
Length:
19 minutes
Released:
Apr 10, 2020
Format:
Podcast episode

Description

During a global pandemic, carbon emissions decrease along with the economy and everything else, we discuss if it is a sustained decline or a respite; then we have a short take on what drugs are being pushed forward to fight COVID‐19 and what happens when drugs are used for purposes different than the drug marker's original intention.
Released:
Apr 10, 2020
Format:
Podcast episode

Titles in the series (100)

Environmental, social, and governance (ESG) news and investment research brought to you weekly covering major market trends and new research insights. With topics ranging from climate impact on investment portfolios, corporate actions, trending investment topics, and emerging ESG issues, host Mike Disabato of MSCI ESG Research walk through the latest news and research that is top of mind for MSCI ESG Research clients and partners. MSCI ESG Research products and services are provided by MSCI ESG Research LLC, and are designed to provide in-depth research, ratings and analysis of environmental, social and governance-related business practices to companies worldwide. ESG ratings, data and analysis from MSCI ESG Research LLC are also used in the construction of the MSCI ESG Indexes. MSCI ESG Research LLC is a Registered Investment Adviser under the Investment Advisers Act of 1940 and a subsidiary of MSCI Inc.